[Fundamental study of blood and bone marrow].
The WHO classification incorporated recent advances of immunology, cytogenetics, and molecular biology, which developed from FAB classification based on cell morphology and cytochemistry. One of the most distinct changes was "AML with recurrent genetic abnormalities." The immunological and cytogenetic studies are required to apply the classification to hematopoietic and lymphoid neoplasms in addition to conventional examinations of the blood and bone marrow. The fundamentals of specimen collection, cell counts, morphologic analysis of blood cells, special stains and other laboratory studies were described in related to the management of myeloid leukemias.
Miura
Ikuo
I
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine.
D001792:Blood Platelets; D001854:Bone Marrow Cells / Q000166:cytology / Q000473:pathology; D002454:Cell Differentiation; D003581:Cytodiagnosis; D004906:Erythrocyte Count; D006403:Hematologic Tests; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007951:Leukemia, Myeloid / Q000097:blood* / Q000145:classification / Q000175:diagnosis* / Q000473:pathology; D007958:Leukocyte Count; D010976:Platelet Count